Home/Filings/4/0001209191-23-011455
4//SEC Filing

Cook Jennifer E. 4

Accession 0001209191-23-011455

CIK 0001743881other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 8:19 PM ET

Size

7.1 KB

Accession

0001209191-23-011455

Insider Transaction Report

Form 4
Period: 2021-11-16
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-16+3,5767,152 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-11-163,5760 total
    Common Stock (3,576 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vested as to 50% of the units on November 16, 2020 and the remaining 50% vested on November 16, 2021.

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1
  • filerCIK 0001754371

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 8:19 PM ET
Size
7.1 KB